Low AMH and Fertility: What It Really Means for Your Chances

"Your AMH is low." These four words — delivered after a blood test — send many women into a spiral of fear and despair. The internet does not help: search results often equate low AMH with an end to any hope of natural or assisted conception. The reality is considerably more nuanced — and for most women, considerably more hopeful than their first reaction suggests.

This article explains what AMH actually measures, what a low result does and does not mean for your fertility, what the evidence says about treatment, and what you should do when you receive this result.

What Is AMH and What Does It Measure?

AMH stands for Anti-Mullerian Hormone. It is produced by the granulosa cells of small, early-stage follicles in the ovaries — the primordial and primary follicles that make up the resting egg pool. Because these follicles are continuously present (rather than only active during a specific cycle phase), AMH can be measured on any day of the menstrual cycle.

AMH is the best available blood marker of ovarian reserve — the total number of eggs remaining in the ovaries. A higher AMH reflects a larger resting pool; a lower AMH reflects a smaller pool.

What AMH does NOT measure is egg quality. This distinction is critical and is missed by many patients — and some doctors. A woman with low AMH can have excellent-quality eggs that fertilise well, produce good embryos, and result in healthy pregnancies. A woman with a high AMH (as in PCOS) can have quality issues despite abundant quantity. AMH is a measure of how many eggs remain — not how good they are.

What "Low" Means: The Numbers in Context

Approximate reference ranges used in Indian fertility practice:

• High (often PCOS-associated): Above 4.0 ng/ml
• Normal: 1.5 to 4.0 ng/ml
• Low-normal: 1.0 to 1.5 ng/ml
• Low (diminished reserve): 0.5 to 1.0 ng/ml
• Very low (severely diminished reserve): Below 0.5 ng/ml
• Undetectable: Below 0.1 ng/ml

These ranges are guidelines, not absolute thresholds. A 28-year-old with an AMH of 0.9 ng/ml has a different clinical picture from a 39-year-old with the same result. Age, antral follicle count, and clinical history must all be interpreted alongside the AMH value.

Low AMH and Natural Conception

This is the fact most commonly missed: low AMH does not reliably predict the ability to conceive naturally. AMH predicts ovarian response to stimulation in IVF — how many eggs will be collected per cycle. It does not predict per-cycle fecundability in natural conception, where only one egg needs to ovulate and fertilise.

Studies have consistently shown that AMH is a poor predictor of natural conception rates in women with regular cycles. A woman with low AMH who ovulates regularly each month has a per-cycle pregnancy probability that is not dramatically different from a woman of the same age with normal AMH — because in natural conception, quantity is not the limiting factor.

The clinical implication: low AMH does not mean you should abandon natural attempts — it means you should not wait too long before seeking help, because the pool is smaller and shrinking, and IVF response may be lower than average when treatment is eventually needed.

Low AMH and IVF

In IVF, AMH does matter more than in natural conception — because IVF success depends on collecting multiple eggs to create multiple embryos, from which the best are selected for transfer. Women with low AMH typically produce fewer eggs per stimulation cycle, which means fewer embryos and fewer opportunities for selection.

However, fewer eggs does not mean zero eggs — and zero probability. Many women with AMH in the 0.5 to 1.0 ng/ml range achieve successful IVF outcomes, particularly when:

• Age is on their side — egg quality is preserved even when quantity is reduced
• Stimulation protocols are optimised for low responders (higher starting doses, appropriate trigger choice, careful monitoring)
• Stimulation cycles are accumulated — sometimes two or three collections are combined to reach a sufficient number of frozen embryos before transfer

At Solo Clinic, low responders are managed with highly individualised protocols — not standard doses applied to everyone. The goal is to extract maximum benefit from every stimulation cycle.

What Causes Low AMH?

• Age: The primary driver. AMH declines progressively from the mid-twenties onwards, with acceleration after 35 to 37.
• Genetic factors: Some women have a genetically reduced follicle pool from birth or experience earlier-than-average reserve decline.
• Previous ovarian surgery: Cystectomy for endometriomas or other ovarian cysts can remove healthy ovarian cortex and significantly reduce AMH. The more surgery, the more the impact.
• Autoimmune conditions: Autoimmune oophoritis can damage the follicle pool.
• Chemotherapy and radiation: Gonadotoxic cancer treatments can dramatically and sometimes permanently reduce ovarian reserve.
• Smoking: Associated with accelerated ovarian reserve decline.
• Unknown: In many young women with unexpectedly low AMH, no identifiable cause is found.

What Can Be Done?

The honest answer is that no treatment currently proven to significantly raise AMH is available. AMH reflects the number of follicles remaining — and that number cannot be substantially increased by any current medical intervention.

However, several approaches are used to support the ovaries and maximise the benefit from remaining reserve:

• DHEA supplementation: Some evidence suggests that DHEA (dehydroepiandrosterone) supplementation for 3 to 6 months before IVF may modestly improve ovarian response in poor responders. Used selectively at Solo Clinic — not as a routine add-on, but when clinically indicated.
• CoQ10 (ubiquinol): Supports mitochondrial function in eggs. Reasonable evidence for modest improvement in egg quality in women with diminished reserve.
• Vitamin D optimisation: Severe deficiency — common in India — is associated with impaired ovarian function. Ensuring adequate levels is a low-cost, low-risk intervention.
• Timing: Because reserve continues to decline, acting sooner rather than later is the most important practical recommendation for women with low AMH.

Frequently Asked Questions

Q1. I am 32 with an AMH of 0.7. Should I panic?

No — but you should act. At 32, egg quality is likely still good. An AMH of 0.7 in a 32-year-old means diminished reserve for your age — but it does not mean IVF is impossible or that outcomes will be poor. It means you should not wait years before seeking fertility treatment. A consultation with a fertility specialist now — to assess your AFC and plan the next steps — is the right move.

Q2. Can I get pregnant naturally with low AMH?

Possibly — particularly if you ovulate regularly. As discussed above, AMH predicts IVF response more than natural conception probability. Many women with low AMH conceive naturally. The concern is that with a smaller pool, the window of opportunity is shorter — which argues for not delaying.

Q3. My AMH was 1.1 last year and now it is 0.6. Is this normal?

Some decline over 12 months is expected, particularly as you approach the mid-to-late thirties. However, rapid decline warrants clinical attention. Repeat the AFC and check the FSH alongside AMH. Genetic and autoimmune screening may be appropriate to assess for premature ovarian insufficiency if the decline seems accelerated for your age.

Q4. Should I freeze my eggs if I have low AMH?

This requires careful, honest counselling. With low AMH, each stimulation cycle is likely to produce fewer eggs than average — meaning it may take multiple cycles to accumulate a clinically meaningful number of frozen eggs. The cost, time, and physical investment must be weighed against the expected outcome. A fertility specialist can estimate the likely egg yield based on your specific AMH and AFC, allowing a properly informed decision.